Cargando…
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
The etiology of amyotrophic lateral sclerosis (ALS), a fatal motor neuron disorder characterized by progressive muscle weakness and spasticity, remains largely unknown. Approximately 5–10% of cases are familial, and of those, 15–20% are associated with mutations in the gene encoding Cu/Zn superoxide...
Autores principales: | Juranek, Judyta K., Daffu, Gurdip K., Geddis, Matthew S., Li, Huilin, Rosario, Rosa, Kaplan, Benjamin J., Kelly, Lauren, Schmidt, Ann Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860390/ https://www.ncbi.nlm.nih.gov/pubmed/27242430 http://dx.doi.org/10.3389/fncel.2016.00117 |
Ejemplares similares
-
Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis
por: Juranek, Judyta K., et al.
Publicado: (2015) -
Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1(G93A) murine model of amyotrophic lateral sclerosis in a sex-dependent manner
por: MacLean, Michael, et al.
Publicado: (2021) -
Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis
por: Nowicka, Natalia, et al.
Publicado: (2019) -
RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice
por: Juranek, Judyta K., et al.
Publicado: (2013) -
Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
por: Saccon, Rachele A., et al.
Publicado: (2013)